Barclays »

Athira Pharma shares owned by Barclays

Quarter-by-quarter ownership of Athira Pharma (LONA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $386 42 9.19
2025-09-30 $29 7 4.14

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Athira Pharma

Perceptive Advisors
ADAR1 Capital Management
Acorn Capital Advisors
NEA Management Company
Commodore Capital
TCG Crossover Management
Spruce Street Capital
Kalehua Capital Management
Blackstone Group
Adage Capital Partners GP
Vanguard Capital Management
Seven Fleet Capital Management
Simplify Asset Management
Propel Bio Management
Geode Capital Management

View all funds holding Athira Pharma